Guidelines and definitions for research on epithelial-mesenchymal transition

Affiliations

• 1 Departments of Pharmacology and Pediatrics, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. jingyang@ucsd.edu.
• 2 Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.
• 3 Molecular and Cellular Oncology Lab, Department of Biomedical Molecular Biology, Ghent University, Cancer Research Institute Ghent (CRIG), VIB Center for Inflammation Research, Ghent, Belgium.
• 4 Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles, Bruxelles, Belgium.
• 5 Department of Experimental Medicine 1, Nikolaus-Fiebiger-Center for Molecular Medicine, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
• 6 Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
• 7 Department of Biomedical Science and Bateson Centre, University of Sheffield, Sheffield, UK.
• 8 Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas 'Alberto Sols' (CSIC-UAM), IdiPAZ & Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
• 9 Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology/Institut de Biologia Molecular de Barcelona (IBMB-CSIC), Barcelona, Spain.
• 10 Department of Biomedicine, University of Basel, Basel, Switzerland.
• 11 Department of Biochemistry and Molecular Biology, University of British Columbia and British Columbia Cancer Research Centre, Vancouver, BC, Canada.
• 12 Departments of Cell and Tissue Biology, and Anatomy, University of California at San Francisco, San Francisco, CA, USA.
• 13 Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
• 14 Department of Laboratory Medicine (LABMED), Division of Pathology, Karolinska University Hospital and Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.
• 15 Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) and Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
• 16 Centre for Cancer Biology, An alliance of SA Pathology and University of South Australia, Adelaide, SA, Australia.
• 17 Developmental Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• 18 School of Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
• 19 Department of Medical Neurobiology, Institute for medical Research Israel-Canada and the Safra Center for Neurosciences, Hebrew University of Jerusalem, Hadassah Medical School, Jerusalem, Israel.
• 20 Department of Cancer Biology, Metastasis Research Center, MD Anderson Cancer Center, Houston, TX, USA.
• 21 Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
• 22 Centre for Cancer Biology, an Alliance of SA Pathology and the University of South Australia, Adelaide, SA, Australia.
• 23 Department of Physics, Northeastern University, Boston, MA, USA.
• 24 Department of Anatomic Pathology, The Division of Pathology and Laboratory Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• 25 Department of Medicine (Oncology) and Department of Cell Biology and Physiology, ICCE Institute, Washington University, St. Louis, MO, USA.
• 26 Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• 27 Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• 28 Department of Cell and Developmental Biology, University College London, London, UK.
• 29 Department of Biology, Duke University, Durham, NC, USA.
• 30 Departments of Anatomy and Biochemistry/Biophysics, University of California, San Francisco, School of Medicine, San Francisco, CA, USA.
• 31 Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, Australia.
• 32 Instituto de Neurociencias (CSIC-UMH) Avda Ramon y Cajal s/n, Sant Joan d´Alacant, Spain.
• 33 Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, Lyon, France.
• 34 Institut Curie, PSL Research University, Paris, France.
• 35 INSERM UMR 1186, Integrative Tumor Immunology and Genetic Oncology, Gustave Roussy, University Paris-Saclay, Villejuif, France.
• 36 Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
• 37 Department of Zoology, Graduate School of Science, Kyoto University, Kyoto, Japan.
• 38 RIKEN Center for Biosystems Dynamics Research, Kobe, Japan.
• 39 Centre de Biologie du Développement (CBD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.
• 40 Guangzhou Regenerative Medicine and Health, Guangdong Laboratory, Guangzhou, China.
• 41 School of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Woolloongabba, QLD, Australia.
• 42 Whitehead Institute for Biomedical Research, Department of Biology, MIT Ludwig Center for Molecular Oncology, Massachusetts Institute of Technology, Cambridge, MA, USA.
• 43 Australian Prostate Cancer Research Centre-Queensland (APCRC-Q) and Queensland Bladder Cancer Initiative (QBCI), School of Biomedical Sciences and Institute of Health and Biomedical Innovation, Queensland University of Technology, Woolloongabba, QLD, Australia.
• 44 Department of Computational and Systems Biology and UPMC-Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
• 45 Department of Molecular and Cellular Biochemistry and UK Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA.
• 46 International Research Center for Medical Sciences (IRCMS), Kumamoto University, Kumamoto, Japan. sheng@kumamoto-u.ac.jp.